Bottom line
How much do FSPHX and JEHSX overlap?
50% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 38.4% of FSPHX's assets and 47.4% of JEHSX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FSPHX and JEHSX have in common
| Holding | % of FSPHX | % of JEHSX | Overlap |
|---|---|---|---|
| ELI LILLY and CO | 8.03% | 14.30% | 8.03% |
| Danaher Corp | 6.89% | 1.51% | 1.51% |
| JOHNSON and JOHNSON | 4.91% | 6.33% | 4.91% |
| Thermo Fisher Scientific Inc | 4.33% | 2.67% | 2.67% |
| Unitedhealth Group Inc | 3.49% | 5.95% | 3.49% |
| Gilead Sciences Inc | 2.21% | 2.95% | 2.21% |
| Abbvie Inc | 2.03% | 5.28% | 2.03% |
| MERCK and CO INC | 1.60% | 4.21% | 1.60% |
| Cvs Health Corp | 1.29% | 0.98% | 0.98% |
| Natera Inc | 1.27% | 1.49% | 1.27% |
| Brightspring Health Services Inc | 1.23% | 0.88% | 0.88% |
| Moderna Inc | 1.18% | 0.87% | 0.87% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FSPHX
- Alnylam Pharmaceuticals Inc — 2.40%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
- Ucb Sa — 2.03%
- Bio Techne Corp — 1.70%
- Argenx Se — 1.56%
- Nuvalent Inc — 1.28%
- Viatris Inc — 1.20%
- Cencora Inc — 1.14%
- West Pharmaceutical Svcs Inc — 1.12%
- Agilent Technologies Inc — 1.10%
- Edwards Lifesciences Corp — 1.09%
Only in JEHSX
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
- Intuitive Surgical Inc. — 1.98%
- Amgen Inc. — 1.90%
- Stryker Corporation — 1.87%
- Elevance Health Inc. — 1.63%
- Guardant Health Inc. — 1.28%
- Cardinal Health Inc. — 1.09%
- Royalty Pharma plc — 1.02%
- Tenet Healthcare Corporation — 0.99%
- Kymera Therapeutics Inc. — 0.93%
- Protagonist Therapeutics Inc. — 0.90%
Asset mix
| Asset type | FSPHX | JEHSX |
|---|---|---|
| Stocks | 97.7% | 99.0% |
| Cash & short-term funds | 2.4% | 0.9% |
| Preferred stock | 2.0% | — |
| Bonds | 0.1% | 0.1% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Country mix
| Country | FSPHX | JEHSX |
|---|---|---|
| US | 87.0% | 95.0% |
| NL | 2.4% | 1.0% |
| DK | 2.2% | 0.7% |
| GB | 2.1% | 0.8% |
| BE | 2.0% | — |
| CH | 1.4% | 0.3% |
| KY | 1.4% | — |
| CA | 1.1% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FSPHX and JEHSX overlap?
What stocks do FSPHX and JEHSX have in common?
Should I own both FSPHX and JEHSX?
Which holds more stocks, FSPHX or JEHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.